552 related articles for article (PubMed ID: 7958890)
21. Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.
Tachibana K; Takayama N; Matsuo K; Kato S; Yamamoto K; Ohyama K; Umezawa A; Takano T
Gene; 1993 Feb; 124(2):231-7. PubMed ID: 8444346
[TBL] [Abstract][Full Text] [Related]
22. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
[TBL] [Abstract][Full Text] [Related]
23. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
24. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.
Adams JM; Gerondakis S; Webb E; Corcoran LM; Cory S
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1982-6. PubMed ID: 6572957
[TBL] [Abstract][Full Text] [Related]
25. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
[TBL] [Abstract][Full Text] [Related]
26. Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene.
Webb E; Adams JM; Cory S
Nature; 1984 Dec 20-1985 Jan 2; 312(5996):777-9. PubMed ID: 6440031
[TBL] [Abstract][Full Text] [Related]
27. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
28. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
29. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
[TBL] [Abstract][Full Text] [Related]
30. Genomic instability in B-cells and diversity of recombinations that activate c-myc.
Janz S; Jones GM; Müller JR; Potter M
Curr Top Microbiol Immunol; 1995; 194():373-80. PubMed ID: 7895512
[TBL] [Abstract][Full Text] [Related]
31. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
[TBL] [Abstract][Full Text] [Related]
32. Myc oncogene activation in B and T lymphoid tumours.
Adams JM; Cory S
Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):59-72. PubMed ID: 2866524
[TBL] [Abstract][Full Text] [Related]
33. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
35. Murine and human 3'IgH regulatory sequences.
Birshtein BK; Chen C; Saleque S; Michaelson JS; Singh M; Little RD
Curr Top Microbiol Immunol; 1997; 224():73-80. PubMed ID: 9308230
[No Abstract] [Full Text] [Related]
36. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
Mol Cell Biol; 1994 Dec; 14(12):7967-74. PubMed ID: 7969136
[TBL] [Abstract][Full Text] [Related]
37. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus.
Pettersson S; Cook GP; Brüggemann M; Williams GT; Neuberger MS
Nature; 1990 Mar; 344(6262):165-8. PubMed ID: 2106628
[TBL] [Abstract][Full Text] [Related]
38. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.
Fahrlander PD; Sümegi J; Yang JQ; Wiener F; Marcu KB; Klein G
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3746-50. PubMed ID: 2987943
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar tethering mediates pairing between the IgH and Myc loci.
Strongin DE; Groudine M; Politz JC
Nucleus; 2014; 5(5):474-81. PubMed ID: 25482199
[TBL] [Abstract][Full Text] [Related]
40. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma.
Rabbitts TH; Forster A; Baer R; Hamlyn PH
Nature; 1983 Dec 22-1984 Jan 4; 306(5945):806-9. PubMed ID: 6419124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
